Document:

SECURITY
AGREEMENT

     

    This
SECURITY AGREEMENT (this
“Agreement”), dated as of January __, 2009, is made by and between Vyteris,
Inc., a Nevada corporation and its wholly owned subsidiary, Vyteris, Inc., a
Delaware corporation (collectively, “Vyteris” or the “Grantor”) Collateral
Agents, LLC, a New York limited liability company, in its capacity as collateral
agent (the “Collateral Agent”) for the benefit of the holders (the
“Noteholders”) of certain notes described below in the aggregate principal
amount of up to $10,000,000 to be issued by Vyteris from time to time on and
after the date hereof, and each of the Noteholders their endorsees, transferees
and assigns all upon terms set forth in that certain Confidential Private
Placement Memorandum, dated November 4, 2009, as same may be amended or
supplemented from time to time (collectively referred to herein as the
“Memorandum”) (the “Memorandum”).

    

    WITNESSETH:

    

    WHEREAS, from time to time on
and after the date hereof, Vyteris may issue up to $10,000,000 of its 0% senior
subordinated convertible promissory notes (as each may be at any time amended,
extended, restated, renewed or modified, each a “Convertible Note,” and
collectively, the “Convertible Notes”) to subscribers for units offered by
Vyteris upon the terms set forth in the Memorandum;

    

    WHEREAS, the Convertible Notes
shall be subordinate in right of payment to up to $3,300,000 of secured debt
(“Senior Debt”) that is due to Ferring Pharmaceuticals, Inc. (the “Senior
Lender”);

    

    WHEREAS, pursuant to the
execution of a Subscription Agreement in the form attached to the Memorandum as
Annex A (each,
a “Subscription Agreement”) each subscriber has become a Noteholder and has
appointed and authorized the Collateral Agent to act as collateral agent under
this Agreement;

    

    WHEREAS, it is a condition
precedent to the obligation of each of the subscribers to purchase a Convertible
Note that the Grantor shall have granted the Collateral Agent a security
interest for the benefit of the Noteholders in the Collateral (as hereinafter
defined) as contemplated by this Agreement; and

    

    WHEREAS, the Grantor expects
to realize direct and indirect benefits as a result of the sale of the
Convertible Notes to the subscribers and desires to grant the Collateral Agent a
security interest for the benefit of the Noteholders in the Collateral as
contemplated by this Agreement.

    

    NOW, THEREFORE, for good and
valuable consideration, the receipt and adequacy of which hereby is
acknowledged, the parties agree as follows:

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

     ARTICLE
I – DEFINITIONS

    

    1.1           This
Agreement is the Security Agreement referred to in the Subscription Agreements
and the Convertible Notes.  As used in this Agreement, the following
terms shall have the meanings respectively set forth below:

    

    “Agreement”
means this Security Agreement, and any extensions, modifications, renewals,
restatements, supplements or amendments hereof.

    

    “Bankruptcy
Code” means Chapter 11 of Title 11 of the United States Code, as amended from
time to time, and any successor statute and all rules and regulations
promulgated thereunder.

    

    “Collateral”
means substantially all of the Grantor’s now owned or hereafter acquired right,
title and interest in and to the General Assets, the Trademarks, the Patents and
the Licenses (other than assets that comprise our PMK Apparatus as described in
the Memorandum).  Without limiting the
generality of the foregoing, “Collateral” shall include any
shares of capital stock and/or other equity interests of any other direct or
indirect subsidiary of the Grantor that is obtained or acquired in the future,
and, in each case, all certificates representing such shares and/or equity
interests and, in each case, all rights, options, warrants, stock, other
securities and/or equity interests that may hereafter be received, receivable or
distributed in respect of, or exchanged for, any of the foregoing and all rights
arising under or in connection with the foregoing securities, including, but not
limited to, all dividends, interest and cash.

     

    “General
Assets” shall have the meaning set forth in Section 2.1 hereof.

    

    “Investment
Collateral” shall have the meaning set forth in Section 7.1 hereof.

    

    “Licenses” shall have the meaning set
forth in Section 2.4 hereof.

    

    “Patents” shall have the meanings set
forth in Section 2.3 hereof.

    

    “PMK Apparatus” shall mean that certain
machinery and apparatus described on Schedule A hereto.

    

    “Requisite
Holders” means, at any time of determination, a majority (i.e., at least 50.1%) of the aggregate principal amount of
outstanding Convertible Notes.

    

    “Secured
Obligations” means any and all present and future obligations of the Grantor
arising under or relating to the Convertible Notes or this Agreement, whether
due or to become due, matured or unmatured, or liquidated or unliquidated,
including interest that accrues after the commencement of any bankruptcy or
insolvency proceeding by or against the Grantor.  For the avoidance of
doubt, the Secured Obligations shall include the obligations of the Grantor to
pay the fees and expenses of the Collateral Agent and to provide indemnity to
the Collateral Agent pursuant to Article XIII
hereof.

    

    “Trademarks” shall have the meanings
set forth in Section 2.2 hereof.

    

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

     

    ARTICLE
II –SECURITY INTERESTS

    

    2.1           Grant of Security Interest
in General Assets.  To secure the complete and timely payment,
performance and satisfaction of all of the Secured Obligations, the Grantor
hereby grants to the Collateral Agent, for the benefit of the Noteholders, a
lien and security interest over all other security interests except as set forth
in Section 2.5 below, with power of sale to the fullest extent permitted by
applicable law, in all of the Grantor’s right, title and interest in and to the
Grantor’s now owned or otherwise existing and hereafter acquired or
arising:

    

    (a)           accounts,
contract rights and all other forms of obligations owing to the Grantor arising
out of the sale or lease of goods or the rendition of services by the Grantor,
irrespective of whether earned by performance, and any and all credit insurance,
guarantees or security therefor;

    

    (b)           books
and records, including ledgers; records indicating, summarizing or evidencing
the Grantor’s properties or assets or liabilities; all information relating to
the Grantor’s business operations or financial condition; and all other computer
programs, disk or tape files, printouts, runs or other computer prepared
information;

    

    (c)           deposit
accounts (as that term is defined from time to time in the Uniform Commercial
Code as in effect in the State of New York);

    

    (d)           all
of the Grantor’s general intangibles and other personal property (including
contract rights, rights arising under common law, statutes or regulations,
chooses or things in action, commercial tort claims, blueprints, drawings,
purchase orders, customer lists, monies due or recoverable from pension funds,
route lists, computer programs, information contained in computer disks or
tapes, literature, reports, catalogs, insurance premium rebates, tax refunds and
tax refund claims);

    

    (e)           goods
(as that term is defined from time to time in the Uniform Commercial Code as in
effect in the State of New York), including (i) all inventory, including
equipment held for lease, whether raw materials, in process or finished, all
material or equipment usable in processing the same and all documents of title
covering any inventory, (ii) all equipment employed in connection with the
Grantor’s business, together with all present and future additions, attachments
and accessions thereto and all substitutions therefor and replacements thereof,
and (iii) all vehicles;

    

    (f)           instruments
and other investment property (as such terms are defined from time to time in
the Uniform Commercial Code as in effect in the State of New York);

    

    (g)           negotiable
collateral, including all of the Grantor’s right, title and interest with
respect to any letters of credit, letter of credit rights, instruments, drafts,
documents and chattel paper (as each term is defined from time to time in the
Uniform Commercial Code as in effect in the State of New York), and any and all
supporting obligations in respect thereof;

    

    
      
         

      

      
        3

        
          

        

      

      
         

      

       

    

    (h)           all
parcels of real property and the related improvements thereto (whether as owner,
lessee or otherwise);

    

    (i)           money
or other assets of the Grantor that now or hereafter come into the possession,
custody or control of the Grantor;

    

    (j)           the
proceeds and products, whether tangible or intangible, of any of the foregoing,
including proceeds of insurance covering any or all of the foregoing, and any
and all of the foregoing, or other tangible or intangible property resulting
from the sale, exchange, collection or other disposition of any of the
foregoing, or any portion thereof or interest therein, and the proceeds thereof;
and

    

    (k)           all
of the Grantor’s right, title and market in and to any shares of capital stock
of any of its subsidiaries and the certificates representing any such
shares;

    

    provided, however, for purposes
of this Agreement, the assets that comprise the Company’s PMK Apparatus, shall
not used to secure the complete and timely payment, performance and satisfaction
of all of the Secured Obligations.  All of the items described in
clauses (a)-(k) in this Section 2.1 are hereinafter individually and/or
collectively referred to as the “General Assets.”

     

    2.2           Grant of Security Interest
in Trademarks. To secure the complete and timely payment, performance and
satisfaction of all of the Secured Obligations, the Grantor hereby grants to the
Collateral Agent, for the benefit of the Noteholders, a lien and security
interest  having priority over all other security interests except as
set forth in Section 2.5 below, including with power of sale to the fullest
extent permitted by applicable law, in all of the Grantor’s right, title and
interest in and to the Grantor’s now owned or otherwise existing and hereafter
acquired or arising: (a) trademarks, trade names, registered trademarks,
trademark applications, service marks, registered service marks and service mark
applications and (b) all renewals thereof, all income, royalties, damages and
payments now and hereafter due and/or payable under and with respect thereto,
including, without limitation, payments under all licenses entered into in
connection therewith and damages and payments for past or future infringements
or dilutions thereof, the right to sue for past, present and future
infringements and dilutions thereof, the goodwill of the Grantor’s business
symbolized by the foregoing and connected therewith and all of the Grantor’s
rights corresponding thereto throughout the world (other than in connection with the
Company’s PMK Apparatus, as described in the Memorandum) (all of the
foregoing items described in the foregoing clauses (a) and (b) in this Section
2.2, are hereinafter individually and/or collectively referred to as the
“Trademarks”); and (c) all proceeds of any and all of the foregoing, including,
without limitation, license royalties and proceeds of the infringement
suits.

    

    
      
         

      

      
        4

        
          

        

      

      
         

      

       

    

    2.3           Grant of Security Interest
in Patents.  To secure the complete and timely payment,
performance and satisfaction of all of the Secured Obligations, the Grantor
hereby grants to the Collateral Agent, for the benefit of the Noteholders,
a  lien and security interest  having priority over all
other security interests except as set forth in Section 2.5 below, including
with power of sale to the fullest extent permitted by applicable law, in all of
the Grantor’s right, title and interest in and to the Grantor’s now owned or
otherwise existing and hereafter acquired or arising: (a) patents and patent
applications and (b) all renewals thereof, all income, royalties, damages and
payments now and hereafter due and/or payable under and with respect to thereto,
including, without limitation, payments under all licenses entered into in
connection therewith and damages and payments for past or future infringements
or dilutions thereof, the right to sue for past, present and future
infringements and dilutions thereof, the goodwill of the Grantor’s business
symbolized by the foregoing and connected therewith and all of the Grantor’s
rights corresponding thereto throughout the world (other than in connection with
the Company’s PMK Apparatus,) (all of the foregoing items described in the
foregoing clauses (a) and (b) in this Section 2.3, are hereinafter individually
and/or collectively referred to as the “Patents”); and (c) all proceeds of any
and all of the foregoing, including license royalties and proceeds of the
infringement suits.  Notwithstanding the foregoing provisions of this
Section 2.3, the Patents shall not include any agreement to purchase a patent in
effect as of the date hereof that by its terms expressly prohibits the grant of
the security contemplated by this Agreement; provided, however, that upon
the termination of such prohibitions for any reason whatsoever, the provisions
of this Section 2.3 shall be deemed to apply thereto automatically.

    

    2.4           Grant of Security Interest
in Trademark and Patent Licenses.  To secure the complete and
timely payment, performance and satisfaction of all of the Secured Obligations,
the Grantor hereby grants to the Collateral Agent, for the benefit of the
Noteholders, a lien and security interest  having priority over all
other security interests except as set forth in Section 2.5 below, including
with power of sale to the fullest extent permitted by applicable law, in all of
the Grantor’s right, title and interest in and to the Grantor’s now owned or
otherwise existing and hereafter acquired or arising: rights under or interests
in any license agreements with any other party, whether the Grantor is a
licensee or licensor under any such license agreement, and the right to use the
foregoing in connection with the enforcement of the Noteholders’ rights under
the Convertible Notes, including the right to prepare for sale and sell any and
all inventory now or hereafter owned by the Grantor and now or hereafter covered
by such licenses (other than in connection with the Company’s PMK Apparatus)
(all of the foregoing are hereinafter referred to collectively as the
“Licenses”).  Notwithstanding the foregoing provisions of this Section
2.4, the Licenses shall not include any license agreement in effect as of the
date hereof that by its terms expressly prohibits the grant of the security
contemplated by this Agreement; provided, however, that upon
the termination of such prohibitions for any reason whatsoever, the provisions
of this Section 2.4 shall be deemed to apply thereto automatically.

    

    2.5           Title; Other
Liens.  Except for (i) the security interest granted to the
Collateral Agent pursuant to this Agreement, (ii) the first lien and security
interest that is held by the Senior Lender to secure the repayment of the Senior
Debt, which shall have priority over the security interest granted to the
Collateral Agent pursuant to this Agreement, the Grantor owns each of the
General Assets, Trademarks, Patents and Licenses free and clear of any and all
liens, claims or security or adverse interests to all or any of the Trademarks,
Patents and Licenses free and clear of any and all liens, claims or security or
adverse interests to all or any of the Trademarks, Patents and Licenses on file
or of record in any public office.

    

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

     

    ARTICLE
III – FURTHER ASSURANCES

    

    3.1           At
any time and from time to time at the request of the Collateral Agent, the
Grantor shall execute and deliver to the Collateral Agent all such financing
statements and other instruments and documents in form and substance
satisfactory to the Collateral Agent as shall be necessary or desirable to fully
perfect, when filed and/or recorded, the security interest in the Collateral
granted to the Collateral Agent for the benefit of the Noteholders pursuant to
Article II of
this Agreement.  The Grantor hereby authorizes the Collateral Agent,
without notice to the Grantor, to file any financing statement and amendments
thereof or continuations thereof, naming the Grantor as debtor and the
Collateral Agent as the creditor.  At any time and from time to time,
the Collateral Agent shall be entitled to file and/or record any or all such
financing statements, instruments and documents held by it, and any or all such
further financing statements, documents and instruments, and to take all such
other actions, as the Collateral Agent may deem appropriate to perfect and to
maintain perfected the security interest granted to it for the benefit of the
Noteholders in Article
II of this Agreement.  Before and after the occurrence of any
default under the Convertible Notes, at the Collateral Agent’s request, the
Grantor shall execute all such further financing statements, instruments and
documents, and shall do all such further acts and things, as may be deemed
necessary or desirable by the Collateral Agent to create and perfect, and to
continue and preserve, an indefeasible security interest in the Collateral in
favor of the Collateral Agent for the benefit of the Noteholders or the priority
thereof, including causing any such financing statements to be filed and/or
recorded in the applicable jurisdiction.

    

    ARTICLE
IV – SECURITY AGREEMENT

    

    4.1           This
Agreement secures the payment of all of the Secured Obligations of the Grantor
now or hereafter existing under the Convertible Notes, whether for principal,
interest, fees, expenses or otherwise, and all of the Secured Obligations of the
Grantor now or hereafter existing under this Agreement and provides for the
application of proceeds from the Collateral, upon the occurrence of an Event of
Default, to satisfy the Secured Obligations, including the irrevocable right of
the Collateral Agent to apply proceeds from Collateral to the payment of any and
all amounts owing to the Collateral Agent pursuant to any of the provisions of
Article X or
Article XIII of
this Agreement prior to making any payment to any or all of the
Noteholders.  

    

    ARTICLE
V – EVENTS OF DEFAULT

    

    5.1           There
shall be an Event of Default (as defined in the Convertible Notes) hereunder
upon the occurrence and during the continuance of an Event of Default under any
of the Convertible Notes.  The Grantor shall promptly notify the
Collateral Agent in writing of any occurrence of an Event of
Default.

    

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

     

    ARTICLE
VI – RIGHTS UPON EVENT OF DEFAULT

    

    6.1           Upon
the occurrence and during the continuance of an Event of Default and provided
that obligations in favor of the Senior Lender have been satisfied, the
Collateral Agent shall have, in any jurisdiction where enforcement hereof is
sought, in addition to all other rights and remedies that the Collateral Agent
may have under applicable law or in equity or under this Agreement, all rights
and remedies of a secured party under the Uniform Commercial Code as enacted in
any jurisdiction.  Without limiting the foregoing, and subject to the
consent of the Requisite Holders, on behalf of the Noteholders: (a) without
demand of performance or other demand, presentment, protest, advertisement or
notice of any kind (except any notice required by law) to or upon the Grantor or
any other person (all of which demands, defenses, advertisements and notices are
hereby waived), may in such circumstances collect, receive, appropriate and
realize upon any or all of the Collateral, and/or may sell, lease, assign, give
option or options to purchase, or otherwise dispose of and deliver any or all of
the Collateral (or contract to do any of the foregoing), in one or more parcels
at public or private sale or sales, at any exchange, broker’s board or office or
elsewhere upon such terms and conditions as the Collateral Agent may deem
advisable, for cash or on credit or for future delivery without assumption of
any credit risk; (b) shall have the right upon any such public sale or sales,
and, to the extent permitted by law, upon any such private sale or sales, to
purchase all or any part of the Collateral so sold, free of any right or equity
of redemption in the Grantor, which right or equity is hereby waived or
released; and (c)  shall apply the net proceeds of any such
collection, recovery, receipt, appropriation, realization or sale, after
deducting all reasonable expenses incurred therein or in connection with the
care or safekeeping of any of the Collateral or in any way relating to the
Collateral or the rights of the Noteholders under this Agreement (including,
without limitation, reasonable attorneys’ fees and expenses) to the payment in
whole or in part of the Secured Obligations, in such order as the Collateral
Agent may elect, and only after such application and after the payment by the
Collateral Agent of any other amount required by any provision of law, need the
Collateral Agent account for the surplus, if any, to the Grantor.  If
any notice of a proposed sale or other disposition of Collateral shall be
required by law, such notice shall be deemed reasonable and proper if given at
least ten (10) days before such sale or other disposition.  The
Grantor shall remain liable for any deficiency if the proceeds of any sale or
other disposition of the Collateral are insufficient to pay the Secured
Obligations and the reasonable fees and disbursements of any attorneys employed
by the Collateral Agent to collect such deficiency.

     

    ARTICLE
VII – VOTING RIGHTS; DIVIDENDS; ETC.

    

    7.1           With
respect to Grantor’s right, title and interest to any Collateral consisting of
securities, partnership interests, joint venture interests, investments or the
like (referred to collectively and individually in this Article VII and in
Article VIII
hereof as the “Investment Collateral”), so long as no Event of Default occurs
and remains continuing:

    

    (a)           the
Grantor shall be entitled to exercise any and all voting and other consensual
rights pertaining to the Investment Collateral, or any part thereof, for any
purpose not inconsistent with the terms of this Agreement or the Convertible
Notes; and

    

    (b)           the
Grantor shall be entitled to receive and to retain and use any and all dividends
or distributions paid in respect of the Investment Collateral.

    

    ARTICLE
VIII – RIGHTS DURING EVENT OF DEFAULT

    

    8.1           With
respect to any Investment Collateral in the possession of the Grantor, so long
as an Event of Default has occurred and is continuing and subject to the
satisfaction of obligations in favor of the Senior Lender:

     

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

     

    
      (a)           at the
option of the Collateral Agent, all rights of the Grantor to exercise the voting
and other consensual rights which it would otherwise be entitled to exercise
pursuant to Section (a) of Article VII hereof,
and to receive the dividends and distributions which it would otherwise be
authorized to receive and retain pursuant to Section (b) of Article VIII hereof,
shall cease, and all such rights thereupon shall become vested in the Collateral
Agent for the benefit of the Noteholders which thereupon shall have the sole
right to exercise such voting and other consensual rights and to receive and to
hold as pledged Investment Collateral such dividends and distributions;
and

    

    

    
      (b)           all
dividends and other distributions that are received by the Grantor contrary to
the provisions of this Agreement shall be held in trust for the benefit of the
Collateral Agent on behalf of the Noteholders, shall be segregated from other
funds of the Grantor and forthwith shall be paid over to Collateral Agent for
the benefit of the Noteholders as pledged Collateral in the same form as so
received (with any necessary endorsements).

    

    

    ARTICLE
IX – GENERAL REPRESENTATIONS, WARRANTIES AND COVENANTS

    

    9.1           The
Grantor represents, warrants and covenants, which representations, warranties
and covenants shall survive execution and delivery of this Agreement, as
follows:

    

    (a)           except
for the security interest granted to the Collateral Agent for the benefit of the
Noteholders herein, the interest and rights disclosed in Section 2.5 and as
disclosed on Schedule
9.1, the Grantor is, and as to Collateral acquired from time to time
after the date hereof, the Grantor will be, the owner of all the Collateral free
from any lien, security interest, encumbrance or other right, title or interest
of any person, and the Grantor shall defend the Collateral against all claims
and demands of all persons at any time claiming the same or any interest therein
adverse to the Collateral Agent for the benefit of the Noteholders;

    

    (b)           there
is no financing statement (or similar statement or instrument of registration
under the law of any jurisdiction) now on file or registered in any public
office covering any interest of any kind in the Collateral, or intended to cover
any such interest that has not been terminated or released by the secured party
named therein, and so long as any Convertible Notes remain outstanding or any of
the Secured Obligations of the Grantor remain unpaid, the Grantor will not
execute and there will not be on file in any public office any financing
statement (or similar statement or instrument of registration under the law of
any jurisdiction) or statements relating to the Collateral, except financing
statements filed or to be filed in respect of and covering the security interest
hereby granted to the Collateral Agent for the benefit of the
Noteholders;

    

    (c)           at
the Grantor’s own expense, the Grantor will keep the Collateral (i) in good
condition at all times (normal wear and tear excepted) and maintain same in
accordance with all manufacturer’s specifications and requirements, and (ii)
free and clear of all liens and encumbrances, except for the liens granted
hereby; and without the consent of the Collateral Agent, the Grantor will not
sell, transfer, change the registration, if any, dispose of, attempt to dispose
of, substantially modify or abandon the Collateral or any part thereof other
than sales of inventory in the ordinary course of business and the disposition
of obsolete or worn-out equipment in the ordinary course of business;
and

    

    
      
         

      

      
        8

        
          

        

      

      
         

      

       

    

    (d)           the
chief executive office and chief place of business of Vyteris is located at
13-01 Pollitt Drive, Fair Lawn, NJ 07410.  The Grantor will not move
its chief executive office and chief place of business until (i) it shall have
given to the Collateral Agent not less than 30 days’ prior written notice of its
intention to do so, clearly describing such new location and providing such
other information in connection therewith as the Collateral Agent may reasonably
request, and (ii) with respect to such new location, it shall have taken such
action, satisfactory to the Collateral Agent, to maintain the security interest
of the Collateral Agent, in favor of the Noteholders, in the Collateral.; and 

    

    ARTICLE
X – FEES, COSTS AND EXPENSES

    

    10.1         The
Grantor shall pay any and all reasonable costs and expenses incurred by the
Collateral Agent, including, without limitation, reasonable costs and expenses
relating to all waivers, releases, discharges, satisfactions, modifications and
amendments of this Agreement, the administration and holding of the Collateral,
insurance expenses, and the enforcement, protection and adjudication of the
parties’ rights hereunder by the Collateral Agent, including, without
limitation, the reasonable disbursements, expenses and fees of the attorneys the
Collateral Agent may retain, if any.

    

    10.2         Upon
the execution of this Agreement, Grantor will pay the Collateral Agent a fee of
$5,000 for agreeing to act as Collateral Agent hereunder and for reviewing and
becoming familiar with the transaction documents.  Upon the
occurrence of an Event of Default, the Grantor shall pay the Collateral Agent an
hourly fee of $500 for services rendered pursuant to this Agreement. The
Collateral Agent is hereby authorized to deduct any sums due the Collateral
Agent from the Collateral or proceeds therefrom in the Collateral Agent’s
possession if not paid on a prompt basis by the Grantor pursuant to Section 10.3
below.  All unpaid payments due to the Collateral Agent pursuant to
this Agreement shall be pari passu to the
Noteholder’s interests in the Convertible Notes. 

    

    10.3         All
advances, charges, costs and expenses, including reasonable attorneys' fees and
disbursements (collectively, “Costs and Expenses”), incurred or paid by the
Collateral Agent in exercising any right, privilege, power or remedy conferred
by this Agreement or in the enforcement or attempted enforcement thereof, shall
be secured hereby and shall become a part of the Secured Obligations and shall
be paid to the Collateral Agent by the Grantor, immediately upon demand,
together with interest thereon from the date of demand at a rate of 6% per
annum.  To the extent that the Costs and Expenses are not paid
promptly by the Grantor, the Collateral Agent may request each Noteholder to
deposit with it, in proportion to their initially purchased respective principal
amounts of Convertible Notes, sufficient sums to cover the Costs and
Expenses.  To the extent Costs and Expenses are not paid to the
Collateral Agent by the Grantor or the Noteholders, the Collateral Agent, in
addition to any other rights granted under this Agreement, is hereby authorized
to deduct the aggregate of unpaid Costs and Expenses from the Collateral or
proceeds therefrom.

    

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

     

    ARTICLE
XI – CONTINUING EFFECT

    

    11.1         This
Agreement shall remain in full force and effect and continue to be effective
should any petition be filed by or against the Grantor for liquidation or
reorganization, should the Grantor become insolvent or make an assignment for
the benefit of creditors or should a receiver or trustee be appointed for all or
any significant part of the Grantor’s assets, and shall continue to be effective
or be reinstated, as the case may be, if at any time payment and performance of
the Secured Obligations, or any part thereof, is, pursuant to applicable law,
rescinded or reduced in amount, or must otherwise be restored or returned by the
Collateral Agent, whether as a “voidable preference,” “fraudulent conveyance” or
otherwise, all as though such payment or performance had not been
made.  In the event that any payment or any part thereof is rescinded,
reduced, restored or returned, the Secured Obligations shall be reinstated and
deemed reduced only by such amount paid and not so rescinded, reduced, restored
or returned.

    

    ARTICLE
XII – TERMINATION; RELEASE OF THE GRANTOR

    

    12.1         This
Agreement shall be terminated and all Secured Obligations of the Grantor
hereunder shall be released when all Secured Obligations of the Grantor have
been paid in full or upon such release of the Grantor's Secured Obligations
hereunder or, with respect to any Convertible Note, when such Convertible Note
shall no longer be outstanding. Upon such termination, the Collateral Agent
shall return any pledged Collateral to the Grantor, or to the person or persons
legally entitled thereto, and shall endorse, execute, deliver, record and file
all instruments and documents, and do all other acts and things reasonably
required for the return of the Collateral to the Grantor, or to the person or
persons legally entitled thereto, and to evidence or document the release of the
Collateral Agent's interests arising for the benefit of the Noteholders under
this Agreement, all as reasonably requested by, and at the sole expense of, the
Grantor.

    

    ARTICLE
XIII –

    COLLATERAL
AGENT’S APPOINTMENT AS ATTORNEY-IN-FACT

    

    13.1         Powers. The Grantor hereby
appoints the Collateral Agent, and any officer or agent of the Collateral Agent,
with full power of substitution, as its attorney-in-fact with full irrevocable
power and authority in the place of the Grantor and in the name of the Grantor
or in its own name, from time to time in the Collateral Agent’s discretion so
long as an Event of Default has occurred and is continuing, for the purpose of
carrying out the terms of this Agreement, to take any and all appropriate action
and to execute any instrument which may be necessary or desirable to accomplish
the purposes of this Agreement.  Except with respect to those matters
as to which the Collateral Agent is expressly required to act under the terms of
this Article
XIII, the Collateral Agent may act or refrain from acting with the
written consent of Requisite Holders, which Requisite Holders shall have the
right to direct the time, method and place of conducting any proceeding for any
remedy available to the Collateral Agent; provided, however, that such
direction shall not be in conflict with any rule of law or expose the Collateral
Agent to personal liability and the Collateral Agent may take any action deemed
proper by the Collateral Agent, in its discretion, which is not inconsistent
with such direction or the terms of this Agreement.

     

    
      
         

      

      
        10

        
          

        

      

      
         

      

       

    

    Without
limiting the foregoing, so long as an Event of Default has occurred and is
continuing and provided that the Collateral Agent has received instructions from
the Requisite Holders, the Collateral Agent shall have the right, without notice
to, or the consent of, the Grantor, to do any of the following on the Grantor’s
behalf:

     

    (a)           to
pay or discharge any taxes or liens levied or placed on or threatened against
the Collateral;

     

    (b)           to
direct any party liable for any payment under any of the Collateral to make
payment of any and all amounts due or to become due thereunder as the Collateral
Agent direct;

     

    (c)           to
ask for or demand, collect, and receive payment of and receipt for, any payments
due or to become due at any time in respect of or arising out of any
Collateral;

     

    (d)           to
commence and prosecute any suits, actions or proceedings at law or in equity in
any court of competent jurisdiction to enforce any right in respect of any
Collateral;

     

    (e)           to
defend any suit, action or proceeding brought against the Grantor with respect
to any Collateral;

     

    (f)           to
settle, compromise or adjust any suit, action or proceeding described in
subsection (e) above and, to give such discharges or releases in connection
therewith as the Collateral Agent may deem appropriate;

     

    (g)           to
assign any Patent right included in the Collateral of Grantor (along with the
goodwill of the business to which any such patent right pertains), throughout
the world for such term or terms, on such conditions, and in such manner, as the
Collateral Agent shall in its sole discretion determine; and

     

    (h)           generally,
to sell, transfer, pledge and make any agreement with respect to or otherwise
deal with any of the Collateral, and to take, at the Collateral Agent’s option
and the Grantor’s expense, any actions which the Collateral Agent deems
necessary to protect, preserve or realize upon the Collateral and the
Noteholders’ liens on the Collateral and to carry out the intent of this
Agreement, in each case to the same extent as if the Collateral Agent were the
absolute owner of the Collateral for all purposes.

     

    13.2         All
acts done under the foregoing authorization are hereby ratified and
approved.

     

    13.3         Each
Noteholder agrees with all other Noteholders and the Collateral Agent (i) that
it shall not, and shall not attempt to, exercise any rights with respect to its
security interest in the Collateral, other than pursuant to this Agreement, or
take or institute any action against the Collateral Agent or any of the other
Noteholders in respect of the Collateral or its rights hereunder (other than any
such action arising from the breach of this Agreement) and (ii) that such
Noteholder has no other rights with respect to the Collateral other than as set
forth in this Agreement and the other transaction documents.

    

    
      
         

      

      
        11

        
          

        

      

      
         

      

    

     

    ARTICLE
XIV – COLLATERAL AGENT

    

    14.1         By
their execution of Subscription Agreements in the form attached to the
Memorandum as Annex
A, the Noteholders have authorized the Collateral Agent to exercise for
the benefit of the Noteholders all rights, powers and remedies provided to it
under or pursuant to this Agreement, including all rights, powers and remedies
upon an Event of Default, subject always to the terms, conditions, limitations
and restrictions provided in this Agreement.  Except with respect to
those matters as to which the Collateral Agent is expressly required to act
under the terms of this Article XIV, the Collateral Agent may act or refrain
from acting with the written consent of the Requiste Holders, which Requisite
Holders shall have the right to direct the time, method and place of conducting
any proceeding for any remedy available to the Collateral Agent; provided, however, that such
direction shall not be in conflict with any rule of law or expose the Collateral
Agent to personal liability, and the Collateral Agent may take any action deemed
proper by the Collateral Agent, in its discretion, which is not inconsistent
with such direction or the terms of this Agreement.

    

    14.2         The
Collateral Agent shall have no duties or responsibilities except those expressly
set forth in this Agreement.  Neither the Collateral Agent nor any of
its partners, members, shareholders, officers, directors, employees or agents
shall be liable for any action taken or omitted by it as such under the
Agreement or hereunder or in connection herewith or therewith, be responsible
for the consequence of any oversight or error of judgment or answerable for any
loss, unless caused by its or their gross negligence or willful misconduct
as determined by a final judgment (not subject to further appeal) of a court of
competent jurisdiction.  The duties of the Collateral Agent shall be
mechanical and administrative in nature; the Collateral Agent shall not have by
reason of the Agreement or any other transaction document a fiduciary
relationship in respect of any Grantor or any Noteholder; and nothing in the
Agreement or any other transaction document, expressed or implied, is intended
to or shall be so construed as to impose upon the Collateral Agent any
obligations in respect of the Agreement or any other transaction document except
as expressly set forth herein and therein.

    

    14.3. The
Collateral Agent shall not be responsible to the Grantor or any Noteholder for
any recitals, statements, information, representations or warranties herein or
in any document, certificate or other writing delivered in connection herewith,
or for the execution, effectiveness, genuineness, validity, enforceability,
perfection, collectibility, priority or sufficiency of the Agreement or any
other transaction document, or for the financial condition of the Grantor or the
value of any of the Collateral, or be required to make any inquiry concerning
either the performance or observance of any of the terms, provisions or
conditions of the Agreement or any other transaction document, or the financial
condition of the Grantor, or the value of any of the Collateral, or the
existence or possible existence of any default or Event of Default under the
Agreement, the Convertible Notes or any of the other transaction
documents.

    

    
      
         

      

      
        12

        
          

        

      

      
         

      

       

    

    14.4.        The
Collateral Agent shall be entitled to rely, and shall be fully protected in
relying, upon any writing, resolution, notice, statement, certificate, telex,
teletype or telecopier message, cablegram, radiogram, order or other document or
telephone message signed, sent or made by the proper person or entity, and, with
respect to all legal matters pertaining to the Agreement and the other
transaction documents and its duties thereunder, upon reasonable advice of
counsel selected by it and upon all other matters pertaining to this Agreement
and the other transaction documents and its duties thereunder, upon advice of
other experts selected by it. Anything to the contrary notwithstanding and
until such time as the Collateral Agent takes any action upon the instructions
of the Requisite Holders, the Collateral Agent shall have no obligation
whatsoever to any Noteholder to assure that the Collateral exists or is owned by
the Grantor or is cared for, protected or insured or that the liens granted
pursuant to the Agreement have been properly or sufficiently or lawfully
created, perfected, or enforced or are entitled to any particular
priority.

    

    14.5. Notwithstanding
anything in this Agreement to the contrary, none of the provisions of this
Agreement shall be construed to require the Collateral Agent to expend or risk
its own funds or otherwise incur any liability (financial or otherwise) in the
performance of any of its duties hereunder, or in the exercise of any of its
rights or powers if it shall have reasonable grounds for believing that
repayment of such funds or indemnification satisfactory to it against such risk
or liability is not assured to it.  In no event shall the Collateral
Agent be liable (a) for any consequential, punitive or special damages or
(b) for the acts or omissions of its nominees, correspondents, designees,
subagents or subcustodians.  The Collateral Agent shall not incur any
liability for not performing any act or fulfilling any duty, obligation or
responsibility hereunder by reason of any occurrence beyond the control of the
Collateral Agent (including any act or provision of any present or future law or
regulation or governmental authority, any act of God or war, or the
unavailability of the Federal Reserve Bank wire or telex or other wire or
communication facility).

    

    14.6         The
Collateral Agent shall not be required or bound to make any investigation into
the facts or matters stated in any resolution, certificate, statement,
instrument, opinion, report, notice, request, consent, entitlement order,
approval or other paper or document.  The Collateral Agent may execute
any of the powers under the Security Agreement or perform any duties hereunder
either directly or by or through agents, attorneys, custodians or nominees
appointed with due care, and shall not be responsible or liable for the acts or
omissions, including any willful misconduct or gross negligence, on the part of
any agent, attorney, custodian or nominee so appointed.

    

    14.7         The
Grantor agrees to be responsible to indemnify and hold the Collateral Agent and
its directors, employees, officers, agents, successors and assigns harmless from
and against any and all losses, claims, damages, liabilities and expenses,
including reasonable costs of investigation and reasonable counsel fees and
expenses that may be imposed on the Collateral Agent or incurred by it in
connection with its acceptance of its appointment as the Collateral Agent
hereunder or the performance of its duties hereunder, except as a result of the
Collateral Agent’s gross negligence or willful misconduct.  Such
indemnity includes all losses, damages, liabilities and expenses (including
reasonable counsel fees and expenses) incurred in connection with any litigation
(whether at the trial or appellate levels) arising from this Agreement or
involving the subject matter hereof.  The indemnification provisions
contained in this Section 14.7 are in addition to any other rights any of the
indemnified parties may have by law or otherwise and shall survive the
termination of this Agreement or the resignation or removal of the Collateral
Agent.

    

    
      
         

      

      
        13

        
          

        

      

      
         

      

       

    

    14.8         Any
corporation or other entity whatsoever into which the Collateral Agent may be
merged or converted or with which it may be consolidated, any corporation or
other entity whatsoever resulting from any merger, conversion or consolidation
to which the Collateral Agent shall be a party or any corporation or other
entity whatsoever succeeding to the business of the Collateral Agent shall be
the successor of the Collateral Agent hereunder without the execution or filing
of any paper with any party hereto except where an instrument of transfer or
assignment is required by law to effect such succession.

    

    14.9         The
Collateral Agent shall provide Noteholders with a notice of an Event of Default
either by email (if available) or in accordance with the provisions of Article
XVIII.

    

    14.10       The
Collateral Agent may generally engage in any kind of business with any
Noteholder as if it had not entered into this Agreement.  The
Collateral Agent and its affiliates and their officers, directors, employees,
and agents (including legal counsel) may hereafter be engaged in one or more
transactions with any Noteholder or may act as trustee, agent or representative
of any Noteholder, or otherwise be engaged in other transactions with such
parties (collectively, the “Other
Activities”).  Without limiting the forgoing, Collateral Agent
and its affiliates and their officers, directors, employees, and agents
(including legal counsel) shall not be responsible to account to any Noteholder
for such other activities.

     

    14.11       The
Collateral Agent may resign and be discharged of its duties hereunder at any
time by giving written notice of such resignation to the other parties hereto,
stating the date such resignation is to take effect.  Within twenty
(20) days of the giving of such notice, a successor collateral agent shall be
appointed by the Requisite Holders; provided, however, that if the
Noteholders are unable so to agree upon a successor within such time period, and
notify the Collateral Agent during such period of the identity of the successor
collateral agent, the successor collateral agent may be a person designated by
the Collateral Agent, and any and all fees of such successor collateral agent
shall be an obligation of the Grantor. The Collateral Agent shall continue to
serve until the effective date of the resignation or until its successor accepts
the appointment and receives the Collateral held by the Collateral Agent but
shall not be obligated to take any action hereunder.  The Collateral
Agent may deposit any Collateral with the Supreme Court of the State of New York
for New York County or any such other court in New York State that accepts such
Collateral. Upon the acceptance of any appointment as Collateral Agent hereunder
by a successor collateral agent, such successor Collateral Agent shall thereupon
succeed to and become vested with all the rights, powers, privileges and duties
of the retiring agent and the retiring agent shall be discharged from its duties
and obligations under the Agreement.  After any retiring agent’s
resignation or removal hereunder as agent, the provisions of the Agreement shall
inure to its benefit as to any actions taken or omitted to be taken by it while
it was agent.

    

    ARTICLE
XV – GOVERNING LAW

    

    15.1         THIS
AGREEMENT SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH AND GOVERNED BY THE
LAWS OF THE STATE OF NEW YORK APPLICABLE TO AGREEMENTS TO BE PERFORMED WHOLLY
WITHIN SUCH JURISDICTION.

    

    
      
         

      

      
        14

        
          

        

      

      
         

      

       

    

    ARTICLE
XVI – ASSIGNMENT

    

    16.1         This
Agreement shall create a continuing security interest in the Collateral and
shall be binding upon the Grantor and the Grantor’s successors and assigns;
inure, together with the rights and remedies of the Collateral Agent hereunder,
in favor of the Noteholders and their successors, transferees and assigns; and
be severable in the event that one or more of the provisions herein is
determined to be illegal or unenforceable.  Without limiting the
generality of the foregoing, the Noteholders may assign or otherwise transfer
any portion of the Convertible Note, in accordance with the terms of the
Convertible Note, to any other person or entity, and such other person or entity
shall thereupon become vested with all the benefits and obligations in respect
thereof granted to the Noteholders (including the beneficial interest in the
rights and benefits granted to the Collateral Agent for the benefit of the
Noteholders) herein or otherwise.  The Grantor shall promptly provide
the Collateral Agent with notice of any such assignment or transfer of a
Convertible Note by any Noteholder.

    

    ARTICLE
XVII – AMENDMENT

    

    17.1         The
terms of this Agreement may be amended only with the written consent of the
Requisite Holders and the written consent of the Collateral Agent.

    

    ARTICLE XVIII-MISCELLANEOUS.

    

    18.1  No
course of dealing between the Grantor and the Noteholders, nor any failure to
exercise, nor any delay in exercising, on the part of the Noteholders, any
right, power or privilege hereunder or under the Convertible Notes shall operate
as a waiver thereof; nor shall any single or partial exercise of any right,
power or privilege hereunder or thereunder preclude any other or further
exercise thereof or the exercise of any other right, power or
privilege.

    

    18.2  All
of the rights and remedies of the Noteholders with respect to the Collateral,
whether established hereby or by the Convertible Notes or by any other
agreements, instruments or documents or by law shall be cumulative and may be
exercised singly or concurrently.

    

    18.3.  If
any term, provision, covenant or restriction of this Agreement is held by a
court of competent jurisdiction to be invalid, illegal, void or unenforceable,
the remainder of the terms, provisions, covenants and restrictions set forth
herein shall remain in full force and effect and shall in no way be affected,
impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same
or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the
intention of the parties that they would have executed the remaining terms,
provisions, covenants and restrictions without including any of such that may be
hereafter declared invalid, illegal, void or unenforceable.

    

    
      
         

      

      
        15

        
          

        

      

      
         

      

       

    

    18.4   No
waiver of any default with respect to any provision, condition or requirement of
this Agreement shall be deemed to be a continuing waiver in the future or a
waiver of any subsequent default or a waiver of any other provision, condition
or requirement hereof, nor shall any delay or omission of any party to exercise
any right hereunder in any manner impair the exercise of any such
right.

    

    18.5.        The
Noteholders, Grantor and Collateral Agent agree that all proceedings
concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement (whether brought against a party hereto or its
respective affiliates, directors, officers, shareholders, partners, members,
employees or agents) shall be commenced exclusively in the state and federal
courts sitting in the City of New York, Borough of Manhattan.  Each
party  hereby irrevocably submits to the exclusive jurisdiction of the
state and federal courts sitting in the City of New York, Borough of Manhattan
for the adjudication of any dispute hereunder or in connection herewith or with
any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any proceeding, any claim that it is not
personally subject to the jurisdiction of any such court, that such proceeding
is improper. Each party hereto hereby irrevocably waives personal service of
process and consents to process being served in any such proceeding by mailing a
copy thereof via registered or certified mail or overnight delivery (with
evidence of delivery) to such party at the address in effect for notices to it
under this Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall
be deemed to limit in any way any right to serve process in any manner permitted
by law.  Each party hereto hereby irrevocably waives, to the fullest
extent permitted by applicable law, any and all right to trial by jury in any
legal proceeding arising out of or relating to this Agreement or the
transactions contemplated hereby.

    

    18.6  This
Agreement may be executed in any number of counterparts, each of which when so
executed shall be deemed to be an original and, all of which taken together
shall constitute one and the same Agreement. In the event that any signature is
delivered by facsimile transmission, such signature shall create a valid binding
obligation of the party executing (or on whose behalf such signature is
executed) the same with the same force and effect as if such facsimile signature
were the original thereof.

    

    18.7    Nothing in this Agreement shall be construed to subject
Collateral Agent or any Noteholder to liability as a partner in Grantor or any
if its direct or indirect subsidiaries that is a partnership or as a member in
Grantor or any of its direct or indirect subsidiaries that is a limited
liability company, nor shall Collateral Agent or any Noteholder be deemed to
have assumed any obligations under any partnership agreement or limited
liability company agreement, as applicable, of any such Grantor or any of its
direct or indirect subsidiaries or otherwise, unless and until any such
Noteholder exercises its right to be substituted for such Grantor as a partner
or member, as applicable, pursuant hereto.

     

    18.9   Any
notice or other communication under the provisions of this Agreement shall be
given in writing and delivered in person, by reputable overnight courier or
delivery service, by facsimile machine (receipt confirmed) with a copy sent by
first class mail on the date of transmissions, or by registered or certified
mail, return receipt requested, directed to such party’s addresses set forth
below (or to any new address of which any party hereto shall have informed the
others by the giving of notice in the manner provided herein):

    

    
      
         

      

      
        16

        
          

        

      

      
         

      

    

     

    In the
case of the Collateral Agent, to:

    

    Collateral
Agents, LLC,

    111 West
57th Street, Suite 1416,

    New York,
NY 10019

    Fax:
(212) 245-9102

    

    In the
case of the Noteholder, to:

    

    To the
address and telecopier number set forth on

    the
Omnibus signature page to the Subscription Agreement. 

    

    In the
case of Grantor, to:

    

    Vyteris,
Inc. (both the Nevada and Delaware corporations)

    13-01
Pollitt Drive

    Fair
Lawn, NJ 07410

    Fax:
(201) 625-6397

    

    With a
copy to:

    

    Jolie
Kahn, Esq.

    61
Broadway, Suite 2820

    New York,
NY 10006

    Fax:
(866) 705-3071

     

    [Remainder
of page intentionally left blank]

    
      
         

      

      
        17

        
          

        

      

      
         

      

    

    IN WITNESS WHEREOF, the
undersigned have executed this Security Agreement by its duly authorized officer
as of the date first written above.

     

    
      
        
          
            
              
                	
                        VYTERIS,
      INC., a Nevada corporation

                      
	 
      
	
                        By:

                      	 
      
	
                        Name:

                      	 
      
	
                        Title:

                      	 
      
	 
      
	
                        VYTERIS,
      INC., a Delaware corporation

                      
	 
      
	
                        By:

                      	 
      
	
                        Name:

                      	 
      
	
                        Title:

                      	 
      
	 
      
	
                        COLLATERAL
      AGENTS, LLC

                      
	 
      
	
                        By:

                      	 
      
	 
      	
                        Name:

                      
	 
      	
                        Title:

                      
	 
      
	
                        NOTEHOLDER

                      
	 
	
                        See
      Omnibus Signature Page to Subscription
Agreement

                      

              

            

          

        

      

    

    
      
         

      

      
        18

        
          

        

      

      
         

      

    

    SCHEDULE
A

     

    The
PMK150 machine was designed and manufactured by Harro Hofliger (Germany) to
manufacture Vyteris transdermal drug patches. The machine operates in a
continuous mode with the following input materials: PETG cover liner, non-woven
pads, anode and cathode solutions, hydrogel and electrode subassembly. The
electrode subassembly web width is 150mm (1-up lane configuration) The basic
operation is as follows. The PETG cover liner roll is unwound and cavities are
thermoformed. Pre-cut non-woven pads are positioned by hand in the cavities and
then ultrasonically welded to the PETG material. Anode and cathode solutions are
dispensed onto the non-woven pads. In parallel, the hydrogel roll is unwound and
die-cut to provide anode and cathode pucks on a carrier liner. These hydrogel
pucks are laminated in registration to the unwound electrode subassembly
material. The latter material is then laminated in registration to the dosed
PETG cover liner. Finally, the patch is die-cut from the web.

     

    The
PMK300 machine was designed and manufactured by Harro Hofliger (Germany) to
manufacture Vyteris transdermal drug patches. The machine operates in a
continuous mode with the following input materials: PETG cover liner, non-woven,
anode and cathode solutions, hydrogel and electrode subassembly. The subassembly
width is 300mm (2-up lane configuration). The basic
operation is as follows. The PETG cover liner roll is unwound and cavities are
thermoformed. Non-woven pads are cut and automatically placed in the cavities
and then ultrasonically welded to the PETG material. Anode and cathode solutions
are dispensed onto the non-woven pads. In parallel, the hydrogel roll is unwound
and die-cut to provide anode and cathode pucks on a carrier liner. These
hydrogel pucks are laminated in registration to the unwound electrode
subassembly material. The latter material is then laminated in registration to
the dosed PETG cover liner. Finally, the patch is die-cut from the
web.

    
      
         

      

      
        19

        
          

        

      

      
         

      

    

    SCHEDULE
9.1

    

    STATE
OF NEVADA

    OFFICE
OF THE

    SECRETARY
OF STATE

    SCOTT
W. ANDERSON

    Deputy
Secretary

    for
Commercial Recordings

    UCC
DIVISION:

    Tracy
Gillespie, Supervisor

    200 N.
Carson Street

    Carson
City, Nevada 89701-4069

    Telephone
(775) 684-5708

    Fax (775)
684-5630

    Copy
Request

    January
26, 2010

    Job Number:
U20100126-0112

    Reference Number:
0000559600-6

    Expedite: None

    Through
Date:

    The
attached copies are all requested financing statements or federal tax liens and
related subsequent
documentation for the debtor below as filed with the Secretary of State’s
Office,
Uniform Commercial Code Division as of the above through date.

    Document
Number(s)

    2008021754-0

    2009007071-6

    2009007288-5

    Search
Criteria:

    Debtor
Name: VYTERIS, INC.

    Lien
Type: UCC

    Lien
Status: Unlapsed

    Updated
Copies From:

    Nevada
Secretary of State

    Electronic
Filing

    Filing
Officer

    
      
         

      

      
        20Exhibit
10.2

    

    Money4Gold
Holdings, Inc.

    Amendment
to the 2008 Equity Incentive Plan

    

    Money4Gold
Holdings, Inc. amends its 2008 Equity Incentive Plan (the “Plan”) as
follows:

    

    Section 4
of the Plan shall be deleted and replaced by the following:

    

    4.           Common Stock. The
Common Stock subject to Stock Rights shall be authorized but unissued shares of
Common Stock, par value $0.0001, or shares of Common Stock reacquired by the
Company in any manner, including purchase, forfeiture or otherwise. The
aggregate number of shares of Common Stock which may be issued pursuant to the
Plan is 27,000,000 subject to adjustment as provided in Section 14. Any such
shares may be issued under ISOs, Non-Qualified Options, Restricted Stock, RSUs
or SARs, so long as the number of shares so issued does not exceed the
limitations in this Section. If any Stock Rights granted under the Plan shall
expire or terminate for any reason without having been exercised in full or
shall cease for any reason to be exercisable in whole or in part, or if the
Company shall reacquire any unvested shares, the unpurchased shares subject to
such Stock Rights and any unvested shares so reacquired by the Company shall
again be available for grants under the Plan.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00173-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00173-of-00352.parquet"}]]